2024. IN SILICO SCREENING OF EFAVIRENZ AND EFAVIRENZ NICOTINAMIDE COCRYSTAL FOR ITS ACTIVITY AGAINST HIV AND SARS COV-2. Nirma University Journal of Pharmaceutical Sciences. 10, 1 (Aug. 2024), 71–86. DOI:https://doi.org/10.5281/.